Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Five-Week, Multi-center, Phase I Clinical Trial to Evaluate Safety of Homeo-GH After Intra Venus Administration for the Treatment of Graft Versus Host Disease Patients

NCT01318330 is registered in ClinicalTrials.gov with HomeoTherapy Co., Ltd as lead sponsor.

NCT NCT01318330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01318330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Five-Week, Multi-center, Phase I Clinical Trial to Evaluate Safety of Homeo-GH After Intra Venus Administration for the Treatment of Graft Versus Host Disease Patients
Lead sponsor
HomeoTherapy Co., Ltd
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2010
Completion date
June 30, 2012
Enrollment
10 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

graft-vs-host disease